Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01033266 · ClinicalTrials.gov registry record
Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome
A clinical trial, sponsored by University of Oklahoma.
- Completed
- Registry status
- 12
- Enrollment target
NCT01033266: Completed study, sponsored by University of Oklahoma.
NCT01033266 is a clinical trial that has completed, run by University of Oklahoma. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01033266 has completed, sponsored by University of Oklahoma.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Nasal CPAP will improve cardiopulmonary exercise test (CPET) performance in patients with overlap syndrome(COPD and OSA). Nasal CPAP is proven to improve cardiopulmonary exercise testing in patients with OSA. The investigators hypothesis is that patients with overlap syndrome will have a greater improvement in their cardiopulmonary exercise testing besides a possible improvement in their lung function test and airway resistance.
Interventions
- DIAGNOSTIC_TEST CPET
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2009-02-01 |
| Est. Completion | 2014-02-28 |
What the finished NCT01033266 record still lists
NCT01033266 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CPET is the first listed.
NCT01033266 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01033266 about?
NCT01033266 is a clinical study titled "Effect of Nasal CPAP on Cardiopulmonary Exercise Testing in Patients With Overlap Syndrome". Nasal CPAP will improve cardiopulmonary exercise test (CPET) performance in patients with overlap syndrome(COPD and OSA). Nasal CPAP is proven to improve cardiopulmonary exercise testing in patients with OSA. The investigators hypothesis is that patients with overlap syndrome will have a greater imp...
What is the current status of trial NCT01033266?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2009-02-01. Estimated completion is 2014-02-28.
What interventions are being tested in trial NCT01033266?
The interventions under investigation include: CPET (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01033266?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI